Free shipping on all orders over $ 500

 About 1 result found for searched term "2671128-05-3" (0.12 seconds)

Cat.No.  Name Target
M11416 FHD-286 Epigenetic Reader Domain
FHD-286 is a BRG1/BRM ATPase inhibitor, which can be used in the study of BAF-related diseases. Fdd-286 is also the first SMARCA2/SMARCA4 dual inhibitor. It can be used in the study of metastatic melanoma and advanced hematologic tumors.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.